No label defined (Q32330)

No description defined

Update of Vocal Fold Shortening With Retrodisplacement of Anterior Commissure for Voice Feminization.

Language	Label	Description	Also known as
English	No label defined	No description defined	Update of Vocal Fold Shortening With Retrodisplacement of Anterior Commissure for Voice Feminization.

Statements

1 reference

Update of Vocal Fold Shortening With Retrodisplacement of Anterior Commissure for Voice Feminization. (English)

1 reference

stated in

PubMed

abstract

To assess the efficacy and long-term durability of the enhanced technique of Type II Vocal Fold Shortening and Retrodisplacement of the Anterior Commissure (VFSRAC) for voice feminization compared with the preceding Type I method. (English)

source label

OBJECTIVES (English)

subsection NLM category

1

2024

1 reference

A retrospective analysis encompassed 506 patients drawn from a cohort of 1025 MtF transgender women who underwent VFSRAC between 2003 and 2021. (English)

source label

METHODS (English)

subsection NLM category

2

2024

1 reference

The study period included cases from 2015 to 2021, during which the Type II update technique was implemented, involving a modification to the suture technique. (English)

source label

METHODS (English)

subsection NLM category

3

2024

1 reference

Subjective and perceptual evaluations, aerodynamic and acoustic assessments, real-time pitch analysis, and videostroboscopic reviews were conducted pre- and postoperatively in the MtF transgender women cohort. (English)

source label

METHODS (English)

subsection NLM category

4

2024

1 reference

Comparative statistical analyses were performed to discern differences between the earlier Type I method (2003-2014) and the more recent Type II method (2015-2021). (English)

source label

METHODS (English)

subsection NLM category

5

2024

1 reference

The preoperative mean speech fundamental frequency (sF0) for Type II VFSRAC was 134.5 Hz. (English)

source label

RESULTS (English)

subsection NLM category

6

2024

1 reference

Postoperatively, the mean sF0 increased to 196.7 Hz, 212.3 Hz, and 207.5 Hz at 3 months, 6 months, and beyond 1 year, respectively, exceeding outcomes observed with the Type I method. (English)

source label

RESULTS (English)

subsection NLM category

7

2024

1 reference

Postoperative subjective and objective assessments indicated an augmentation in voice femininity. (English)

source label

RESULTS (English)

subsection NLM category

8

2024

1 reference

Acoustic and aerodynamic indices were within the normal range, and the regularity of the vocal fold mucosal wave was preserved within normal parameters. (English)

source label

RESULTS (English)

subsection NLM category

9

2024

1 reference

These results suggest that patients achieved a natural phonation pattern after surgery. (English)

source label

RESULTS (English)

subsection NLM category

10

2024

1 reference

The application of our updated type II VFSRAC has demonstrated feasibility and consistently yielded favorable results for individuals desiring a naturally feminine voice. (English)

source label

CONCLUSIONS (English)

subsection NLM category

11

2024

1 reference